Gemini Slams New York Post for Bad Reporting on Earn Program

Gemini Trust Co., a leading crypto exchange has expressed disappointment and frustration with a recent New York Post’s reporting, asserting that the story it peddled with respect to its Earn Program was not only inaccurate but also a deliberate attempt to manipulate public opinion.

The Allegations

The New York Post reported that Gemini withdrew $282 million from the now-bankrupt Genesis Global in August 2022, insinuating that this action was questionable at best and potentially harmful to investors.

Furthermore, the story hinted at possible mismanagement of funds and portrayed the company and its founders, Cameron and Tyler Winklevoss, in a negative light. In response to these allegations, Gemini took to the X platform to set the record straight. The company vehemently denied any wrongdoing and clarified the nature of the funds in question.

According to Gemini, the $282 million withdrawn from Genesis in August 2022 was not corporate funds nor the personal funds of its founders or their investment firm. Instead, revealed that it was the money belonging to users of the Gemini Earn program.

The exchange went on to accuse Barry Silbert and Digital Currency Group (DCG) of orchestrating a deliberate attempt to manipulate public opinion and distract from their own fraudulent behavior, which is currently under criminal investigation. Gemini suggested that the New York Post had been fed a pre-packaged and fictional story by these parties.

Gemini Sheds Further Light on the Earn Program

To understand the situation fully, it’s crucial to examine the Gemini Earn program and its terms. Gemini highlighted in the tweet that the program allowed it to establish a “liquidity reserve” to benefit Earn users.

In response to market turmoil during the summer of 2022, Gemini stated that it decided to increase this liquidity reserve. As a result, it pulled back $282 million of Earn users’ funds from Genesis on August 9, 2022, and held these funds in the liquidity reserve for the benefit of users.

Gemini stated that increasing the liquidity reserve was a reasonable and prudent option, noting that it shielded Earn users from major exposure to Genesis when it ceased redemptions on November 16, 2022.

Recommended
Price Analysis

Best Crypto Presales To Invest In September 2025 – Top Upcoming Presale Tokens

Best Crypto AI Trading Bots In 2025

Top Meme Coins To Buy In September 2025

Godfrey Benjamin

Benjamin Godfrey is a blockchain enthusiast and journalists who relish writing about the real life applications of blockchain technology and innovations to drive general acceptance and worldwide integration of the emerging technology. His desires to educate people about cryptocurrencies inspires his contributions to renowned blockchain based media and sites. Benjamin Godfrey is a lover of sports and agriculture. Follow him on X, Linkedin

Why trust CoinGape: CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journalists and analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

Investment disclaimer: The content reflects the author’s personal views and current market conditions. Please conduct your own research before investing in cryptocurrencies, as neither the author nor the publication is responsible for any financial losses.

Ad Disclosure: This site may feature sponsored content and affiliate links. All advertisements are clearly labeled, and ad partners have no influence over our editorial content.